Cargando…
Circulating miR-451a levels as a potential biomarker to predict the prognosis of patients with multiple myeloma
The natural course of multiple myeloma (MM) varies greatly between patients. The Revised MM International Staging System (R-ISS) identifies high-risk patients, but it is unsuitable for assessing minimal residual disease (MRD). Furthermore, the focal location of myeloma cells and clonal evolution oft...
Autores principales: | Zhong, Ling, Jin, Xin, Xu, Zhuyu, Zeng, Minghui, Chen, Dongmei, He, Yuan, Zhang, Jianbo, Jiang, Tao, Chen, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517596/ https://www.ncbi.nlm.nih.gov/pubmed/32989397 http://dx.doi.org/10.3892/ol.2020.12126 |
Ejemplares similares
-
miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma
por: Zhong, Ling, et al.
Publicado: (2020) -
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012) -
Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015) -
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
por: Besharat, Z. M., et al.
Publicado: (2023) -
miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
por: Gao, Bo, et al.
Publicado: (2023)